Mark J. Rubash Sells 1,709 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Mark J. Rubash sold 1,709 shares of Intuitive Surgical stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $380.00, for a total value of $649,420.00. Following the completion of the sale, the director now owns 16,051 shares in the company, valued at $6,099,380. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $388.65 on Wednesday. The firm’s 50 day moving average price is $385.34 and its 200-day moving average price is $351.97. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The company has a market cap of $137.86 billion, a PE ratio of 70.15, a P/E/G ratio of 4.93 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.00 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently weighed in on ISRG shares. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Barclays increased their price target on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research note on Thursday, January 25th. Raymond James upped their target price on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Jefferies Financial Group raised their target price on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. Finally, Robert W. Baird reduced their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors have recently modified their holdings of ISRG. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its holdings in shares of Intuitive Surgical by 0.3% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock valued at $3,002,000 after purchasing an additional 27 shares during the last quarter. Advance Capital Management Inc. raised its stake in Intuitive Surgical by 3.8% during the 1st quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock valued at $295,000 after buying an additional 27 shares during the last quarter. Perigon Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 0.5% during the 1st quarter. Perigon Wealth Management LLC now owns 5,363 shares of the medical equipment provider’s stock valued at $2,140,000 after buying an additional 27 shares during the period. Sugarloaf Wealth Management LLC boosted its stake in shares of Intuitive Surgical by 5.7% in the 1st quarter. Sugarloaf Wealth Management LLC now owns 534 shares of the medical equipment provider’s stock worth $213,000 after buying an additional 29 shares during the last quarter. Finally, Sheaff Brock Investment Advisors LLC grew its holdings in shares of Intuitive Surgical by 1.3% in the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 2,226 shares of the medical equipment provider’s stock worth $751,000 after acquiring an additional 29 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.